Cargando…

Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study

Patients with venous thrombosis (VT) are at increased risk of future arterial cardiovascular disease (CVD) (i.e., myocardial infarction, ischemic stroke or peripheral artery disease). We investigated whether shared risk factors for VT and CVD are associated with the levels of procoagulant factors (f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yap, Eng Soo, Lijfering, Willem M., Timp, Jasmijn F., Rosendaal, Frits R., Cannegieter, Suzanne C., Scheres, Luuk J. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Sickle Cell, Thrombosis, and Classical Haematology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928659/ https://www.ncbi.nlm.nih.gov/pubmed/36819164 http://dx.doi.org/10.1002/jha2.618

Ejemplares similares

Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Predicting the risk of recurrent venous thrombosis: What the future might bring
por: Lijfering, Willem M., et al.
Publicado: (2019)

Procoagulant factor levels and risk of venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2020)

Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID‐19 infection
por: Fisher, Lori‐Ann, et al.
Publicado: (2023)

A phase III, randomised, double‐blind, multi‐national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria
por: Jang, Jun Ho, et al.
Publicado: (2022)

Impact of age‐dependent red blood cell parameters on α‐globin gene genotyping in children
por: Nissen, Peter H., et al.
Publicado: (2022)

UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease
por: Buka, Richard J, et al.
Publicado: (2022)

SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity
por: Toomer, Kevin H., et al.
Publicado: (2023)

Red blood cell alloantibodies in paediatric transfusion in sub‐Saharan Africa: A new cohort and literature review
por: Gadji, Macoura, et al.
Publicado: (2023)

Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies
por: Shields, Adrian M., et al.
Publicado: (2023)

Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States
por: Cuker, Adam, et al.
Publicado: (2023)

Family planning needs of young adults with sickle cell disease
por: Linton, Elizabeth A., et al.
Publicado: (2023)

Real‐world complication burden and disease management paradigms in transfusion‐related β‐thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross‐sectional study
por: Kattamis, Antonis, et al.
Publicado: (2023)

Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasia
por: Mukhtar, Ghazel, et al.
Publicado: (2023)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Comparative analysis of opioid use in sickle cell crisis in an urban facility in Ghana
por: Opoku‐Agyakwa, Marian, et al.
Publicado: (2023)

Results of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria
por: Gaya, Anna, et al.
Publicado: (2023)

Clinical and haematological characteristics of 38 individuals with Hb G‐Makassar in Malaysia
por: Esa, Ezalia, et al.
Publicado: (2023)

Impact of COVID‐19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell disease
por: Dubois, Gabin, et al.
Publicado: (2023)

Sickle cell anemia and pregnancy: Profile of hemodynamic changes in sickle cell pregnant women in Kinshasa
por: Mikobi, Tite Minga, et al.
Publicado: (2023)

HLA haplotype frequencies and diversity in patients with hemoglobinopathies
por: Scigliuolo, Graziana M., et al.
Publicado: (2023)

Empowering patients with sickle cell anemia and their families through innovative educational methods
por: Plett, Riley, et al.
Publicado: (2023)

Disease knowledge and health literacy in parents of children with sickle cell disease
por: Ikediashi, Bonaventure G., et al.
Publicado: (2023)

Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020)

A retrospective analysis of venous thromboembolism trends in chemotherapy‐induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administration
por: Bryer, Emily J., et al.
Publicado: (2020)

The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk
por: Khialani, Deeksha, et al.
Publicado: (2020)

Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case‐control study
por: Li‐Gao, Ruifang, et al.
Publicado: (2018)

Factor V levels and risk of venous thrombosis: The MEGA case‐control study
por: Rietveld, Inge M., et al.
Publicado: (2018)

Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower‐leg injury or knee arthroscopy
por: Mohammed, Yassene, et al.
Publicado: (2022)

Plasma exchange for COVID‐19 thrombo‐inflammatory disease
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020)

Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021)

Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crises
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Mild anemia as a single independent predictor of mortality in patients with COVID‐19
por: Tremblay, Douglas, et al.
Publicado: (2021)

In‐hospital mortality in SARS‐CoV‐2 stratified by hemoglobin levels: A retrospective study
por: Al‐Jarallah, Mohammed, et al.
Publicado: (2021)

Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications
por: Mankelow, Tosti J., et al.
Publicado: (2021)

The effect of underlying inflammation on iron metabolism, cardiovascular risk and renal function in patients with type 2 diabetes
por: Ndevahoma, Fransina, et al.
Publicado: (2021)

The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta‐analysis
por: Alcedo, Pedro E., et al.
Publicado: (2020)

Age‐specific differences in the magnitude of malaria‐related anemia during low and high malaria seasons in rural Zambian children
por: Acheampong, Clement O., et al.
Publicado: (2021)

Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review
por: Hermel, Melody, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dbludcrd0v6jp597sn17gjaimn